检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Rechallenge of afatinib for EGFR -mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study).

Taisuke Araki,Shintaro Kanda,Masamichi Komatsu,Kei Sonehara,Kazunari Tateishi,Munetake Takada,Akane Kato, Manabu Yamamoto,Kenichi Nishie,Mineyuki Hama,Toshihiko Agatsuma,Yumiko Kakizaki,Fumiaki Yoshiike,Akemi Matsuo,Tomoshige Chiaki, Kanae Samizo, Yoshiko Takagi, Maki Yamaura,Masayuki Hanaoka,Tomonobu Koizumi

Translational lung cancer research（2023）

引用 1|浏览8
暂无评分
摘要
UMIN Clinical Trial Registry: UMIN000049225.
更多
查看译文
关键词
afatinib,lung cancer,osimertinib,egfr-mutated,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要